ArticleBMJ global health2022
COVID-19 public health and social measures: a comprehensive picture of six Asian countries.
Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Article
- From response-to-routine: embedding humanitarian supply evaluation in Singapore's health and community care systems.Frontiers in health services · 2026Article
- Building systems for preparedness: Global scoping studies on institutional governance and National Public Health Agencies.PLOS global public health · 2026Article
- Public health messaging and community engagement during COVID-19: a rapid-review from the Greater Mekong Subregion.One health outlook · 2025Review
- Increase in Antibiotic Utilisation in Primary Care Post COVID-19 Pandemic.Antibiotics (Basel, Switzerland) · 2025Article
- Public Healthcare Procurement Strategies in Response to the COVID-19 Pandemic: A Scoping Review.International journal of health policy and management · 2025Article
- The Impact of Public Health and Social Measures (PHSMs) on SARS-CoV-2 Transmission in the WHO European Region (2020-2022).Influenza and other respiratory viruses · 2024Article
- Article
- Article
- Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study.The Lancet regional health. Western Pacific · 2024Article
- Corona Virus Disease (COVID-19): Lessons Learned Impact on the Education of Health Professionals.Advances in experimental medicine and biology · 2024Article
- Article
- Prescribing Antibiotics in Public Primary Care Clinics in Singapore: A Retrospective Cohort Study.Antibiotics (Basel, Switzerland) · 2023Article
- Health and Economic Benefits of Air Pollution Reductions in Vietnam During 2020-2021.International journal of public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
The COVID-19 pandemic will not be the last of its kind. As the world charts a way towards an equitable and resilient recovery, Public Health and Social Measures (PHSMs) that were implemented since the beginning of the pandemic need to be made a permanent feature of health systems that can be activated and readily deployed to tackle sudden surges in infections going forward. Although PHSMs aim to blunt the spread of the virus, and in turn protect lives and preserve health system capacity, there are also unintended consequences attributed to them. Importantly, the interactions between PHSMs and their accompanying key indicators that influence the strength and duration of PHSMs are elements that require in-depth exploration. This research employs case studies from six Asian countries, namely Indonesia, Singapore, South Korea, Thailand, the Philippines and Vietnam, to paint a comprehensive picture of PHSMs that protect the lives and livelihoods of populations. Nine typologies of PHSMs that emerged are as follows: (1) physical distancing, (2) border controls, (3) personal protective equipment requirements, (4) transmission monitoring, (5) surge health infrastructure capacity, (6) surge medical supplies, (7) surge human resources, (8) vaccine availability and roll-out and (9) social and economic support measures. The key indicators that influence the strength and duration of PHSMs are as follows: (1) size of community transmission, (2) number of severe cases and mortality, (3) health system capacity, (4) vaccine coverage, (5) fiscal space and (6) technology. Interactions between PHSMs can be synergistic or inhibiting, depending on various contextual factors. Fundamentally, PHSMs do not operate in silos, and a suite of PHSMs that are complementary is required to ensure that lives and livelihoods are safeguarded with an equity lens. For that to be achieved, strong governance structures and community engagement are also required at all levels of the health system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.